The Hydration Pharmaceuticals Co (ASX:HPC) Notes Receivable: A$0.00 Mil (As of Dec. 2025)


What is The Hydration Pharmaceuticals Co Notes Receivable?

The Hydration Pharmaceuticals Co ASX:HPC -20.00% Notes Receivable is A$0.00 Mil as of Dec. 2025. The stock has 3 warning signs investors should review.

The Hydration Pharmaceuticals Co's Notes Receivable for the quarter that ended in Dec. 2025 was A$0.00 Mil.


The Hydration Pharmaceuticals Co Notes Receivable Related Terms


The Hydration Pharmaceuticals Co Notes Receivable Historical Data

* Premium members only.

The historical data trend for The Hydration Pharmaceuticals Co's Notes Receivable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

The Hydration Pharmaceuticals Co Notes Receivable Chart

The Hydration Pharmaceuticals Co Annual Data
Trend Dec21 Dec22 Dec23 Dec24 Dec25
Notes Receivable
0.00 0.00 0.00 0.00 0.00

The Hydration Pharmaceuticals Co Semi-Annual Data
Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Notes Receivable Get a 7-Day Free Trial Premium Member Only 0.00 0.00 0.00 0.00 0.00

The Hydration Pharmaceuticals Co Notes Receivable Calculation

Notes Receivable is an unconditional promise to receive a definite sum of money at a future date(s) within one year of the balance sheet date or the normal operating cycle, whichever is longer.

Frequently Asked Questions Learn more about Notes Receivable →
What does a Notes Receivable of A$0.00 Mil mean?
The Hydration Pharmaceuticals Co (ASX:HPC) has a Notes Receivable of A$0.00 Mil as of Dec. 2025. Notes Receivable is an unconditional promise to receive a definite sum of money within one year. View historical data on The Hydration Pharmaceuticals Co and its competitors.
Is The Hydration Pharmaceuticals Co's Notes Receivable too high?
The Hydration Pharmaceuticals Co's current Notes Receivable is A$0.00 Mil.
How does The Hydration Pharmaceuticals Co's Notes Receivable compare to SYY and USFD?
The Hydration Pharmaceuticals Co's Notes Receivable of A$0.00 Mil can be compared against companies in the Retail - Defensive industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Notes Receivable for a Retail - Defensive company?
A good Notes Receivable depends on the Retail - Defensive industry context. However, Notes Receivable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Notes Receivable mean?
A high Notes Receivable can signal that a stock is expensive relative to its fundamentals. Notes Receivable is an unconditional promise to receive a definite sum of money within one year. View historical data on The Hydration Pharmaceuticals Co and its competitors. The Hydration Pharmaceuticals Co's current Notes Receivable is A$0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is The Hydration Pharmaceuticals Co stock overvalued right now?
The Hydration Pharmaceuticals Co (ASX:HPC) has a current Notes Receivable of A$0.00 Mil. The current Notes Receivable is A$0.00 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Notes Receivable calculated?
Notes Receivable is calculated from a company's financial statements. For The Hydration Pharmaceuticals Co (ASX:HPC), the current Notes Receivable is A$0.00 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

The Hydration Pharmaceuticals Co Business Description

Address 6 Palmer Parade, Level 2, Cremorne, Melbourne, VIC, AUS, 3121
The Hydration Pharmaceuticals Co Ltd is a consumer products company that markets and sells a range of liquid, tablet and powder Healthy Hydration Solutions products into the USA market, under the Hydralyte brand. Hydralyte collates and translates consumer insights and needs into developing and delivering quality hydration products to market. The Company's business model is an asset light, flexible production model that allows it to outsource manufacturing and packaging to appropriate suppliers.